Allworth Financial’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.11K | Buy |
2,323
+1,947
| +518% | +$4.28K | ﹤0.01% | 3237 |
|
|
2025
Q1 | $605 | Buy |
376
+53
| +16% | +$85 | ﹤0.01% | 3623 |
|
|
2024
Q4 | $433 | Sell |
323
-508
| -61% | -$681 | ﹤0.01% | 3638 |
|
|
2024
Q3 | $2.83K | Buy |
831
+408
| +96% | +$1.39K | ﹤0.01% | 2812 |
|
|
2024
Q2 | $2.12K | Sell |
423
-228
| -35% | -$1.14K | ﹤0.01% | 2897 |
|
|
2024
Q1 | $4.83K | Buy |
651
+228
| +54% | +$1.69K | ﹤0.01% | 2423 |
|
|
2023
Q4 | $4.29K | Sell |
423
-38
| -8% | -$385 | ﹤0.01% | 2334 |
|
|
2023
Q3 | $3.6K | Buy |
461
+38
| +9% | +$296 | ﹤0.01% | 2271 |
|
|
2023
Q2 | $3.48K | Buy |
423
+23
| +6% | +$189 | ﹤0.01% | 2258 |
|
|
2023
Q1 | $2.9K | Buy |
400
+100
| +33% | +$725 | ﹤0.01% | 2252 |
|
|
2022
Q4 | $2.66K | Buy |
300
+164
| +121% | +$1.46K | ﹤0.01% | 2133 |
|
|
2022
Q3 | $2K | Sell |
136
-214
| -61% | -$3.15K | ﹤0.01% | 2134 |
|
|
2022
Q2 | $4K | Buy |
+350
| New | +$4K | ﹤0.01% | 1801 |
|
|
2022
Q1 | – | Sell |
-100
| Closed | -$3K | – | 2181 |
|
|
2021
Q4 | $3K | Sell |
100
-400
| -80% | -$12K | ﹤0.01% | 1637 |
|
|
2021
Q3 | $21K | Buy |
500
+100
| +25% | +$4.2K | ﹤0.01% | 1002 |
|
|
2021
Q2 | $23K | Sell |
400
-300
| -43% | -$17.3K | ﹤0.01% | 808 |
|
|
2021
Q1 | $29K | Buy |
700
+100
| +17% | +$4.14K | ﹤0.01% | 690 |
|
|
2020
Q4 | $42K | Hold |
600
| – | – | ﹤0.01% | 510 |
|
|
2020
Q3 | $17K | Buy |
+600
| New | +$17K | ﹤0.01% | 598 |
|